Hip Arthroscopy Postoperative Opioid Demands
Rush University Medical Center · NCT04094701
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–80 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 170
- US sites recruiting
- 1
- Study start
- October 21, 2020
- Record last updated
- August 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatment arms. The intervention group will receive 5 Norco pills, gabapentin (30 mg, once daily for 10 days following surgery), and Tylenol (1000 mg, three times daily for 10 days following surgery) while the control will receive the standard at our practice of 30 Norco pills.
Being studied: Control Group Regimen; Opioid reduced regimen
Conditions: Opioid Use; Pain; Femoral Acetabular Impingement; Labral Tear, Glenoid
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adult patients age 18-80 years
- English speaking
- Opioid naive patient (defined as not taking opioid pills within 6 weeks prior to surgery), confirmed by checking the Illinois Prescription monitoring program
- Primary hip arthroscopy
- Written and informed consent for study participation
Exclusion Criteria
- Minors (\<18 years of age)
- Opioid tolerant patients
- Revision surgery
- Prior infections of the operative joint
- History of active malignancy within the past 5 years
- Chronic pain conditions including low back pain, chronic pain syndrome, fibromyalgia
- History of alcohol or other substance use disorder
- Other disease states including rheumatologic conditions, diabetes mellitus, hypo/hyperthyroidism, depression, anxiety
- Grade IV chondral defects
Recruiting US locations
Rush University Medical Center
Chicago, IL 60612
Site contact: Carla M Edwards, PhD · 312-563-5735 · carla_edwards@rush.edu
Study contacts (from the official record)
- Carla M. Edwards · 312-563-5735 · carla_edwards@rush.edu
Similar studies in Illinois
All arthritis studies in Illinois →- RecruitingPhase 2
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Merck Sharp & Dohme LLC
- Location
- Chicago, IL + 35 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Medipost, Inc.
- Location
- Chicago, IL + 33 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or…
AbbVie
- Location
- Orland Park, IL + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With…
Amgen
- Location
- Chicago, IL + 73 other US sites
- Eligibility basics
- Ages 18+